Home › Oral Cancer › California › Orange
Oral Cancer clinical trials in Orange, CA
3 studies for Oral Cancer are looking for participants at sites in and around Orange (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer
RecruitingPhase 2
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
RecruitingPhase 2
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
RecruitingPhase 2
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
About Oral Cancer
Oral cancer can form in the mouth or throat but usually begins in the tongue and floor of the mouth. Read about the common oral cancer symptoms.
More about Oral Cancer on MedlinePlus
Oral Cancer trials in other cities
- Atlanta, GA9 studies
- St. Louis, MO8 studies
- New York City, NY8 studies
- Chicago, IL8 studies
- Durham, NC7 studies
- Houston, TX7 studies
- Pittsburgh, PA7 studies
- Milwaukee, WI7 studies
- Portland, OR7 studies
- Ann Arbor, MI7 studies
- Kansas City, MO7 studies
- Richmond, VA7 studies
Other studies in Orange
- Non-Small Cell Lung Cancer25 studies
- Metastatic Cancer20 studies
- Colorectal Cancer16 studies
- Ovarian Cancer16 studies
- Pancreatic Cancer15 studies
- Melanoma14 studies
- Liver Cancer (Hepatocellular Carcinoma)14 studies
- Breast Cancer14 studies
- Lung Cancer14 studies
- Prostate Cancer14 studies
- Stomach Cancer13 studies
- Cancer (all types)13 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.